BACKGROUND: Heavy drinking may increase blood glucose levels. Moreover, in alcohol-dependent subjects, glucose may play a putative role in alcohol preference. METHODS: This study investigated the relationship between blood glucose levels and both alcohol heavy drinking and craving in alcohol-dependent subjects participating in the COMBINE Study. The primary objective was to evaluate the relationship between baseline (pretreatment) glucose levels and percentage of heavy drinking day (PHDD) during treatment. The secondary objective was to evaluate the relationship between glucose levels, baseline PHDD, and craving measured by the Obsessive Compulsive Drinking Scale (OCDS). RESULTS: This analysis consisted of 1,324 participants. Baseline glucose levels were significantly and positively associated with PHDD during treatment [F(1, 1225) = 5.21, p = 0.023], after controlling for baseline PHDD [F(1, 1225) = 36.25, p < 0.0001], gender [F (1, 1225) = 3.33, p = 0.07], and body mass index (BMI) [F(1, 1225) = 0.31, p = 0.58]. Higher glucose levels at baseline were associated with a higher percentage of PHDD at pretreatment [F(1, 1304) = 5.96, p = 0.015], after controlling for gender [F(1, 1304) = 0.29, p = 0.59] and BMI [F(1, 1304) = 0.90, p = 0.34]. Glucose was not significantly associated with the OCDS total score [F(1, 1304) = 0.12, p = 0.73], the OCDS Obsessive subscale [F(1, 1304) = 0.35, p = 0.56], or the OCDS Compulsive subscale [F(1, 1304) = 1.19, p = 0.28] scores, after controlling for gender and BMI. DISCUSSION: A link between pretreatment glucose levels and heavy drinking during treatment was found, suggesting a role of glucose in predicting heavy alcohol consumption. Although caution is needed in the interpretation of these results, elevated glucose and heavy drinking may be affected by a common mechanism and manipulations affecting glucose regulation may influence alcohol consumption.
RCT Entities:
BACKGROUND: Heavy drinking may increase blood glucose levels. Moreover, in alcohol-dependent subjects, glucose may play a putative role in alcohol preference. METHODS: This study investigated the relationship between blood glucose levels and both alcohol heavy drinking and craving in alcohol-dependent subjects participating in the COMBINE Study. The primary objective was to evaluate the relationship between baseline (pretreatment) glucose levels and percentage of heavy drinking day (PHDD) during treatment. The secondary objective was to evaluate the relationship between glucose levels, baseline PHDD, and craving measured by the Obsessive Compulsive Drinking Scale (OCDS). RESULTS: This analysis consisted of 1,324 participants. Baseline glucose levels were significantly and positively associated with PHDD during treatment [F(1, 1225) = 5.21, p = 0.023], after controlling for baseline PHDD [F(1, 1225) = 36.25, p < 0.0001], gender [F (1, 1225) = 3.33, p = 0.07], and body mass index (BMI) [F(1, 1225) = 0.31, p = 0.58]. Higher glucose levels at baseline were associated with a higher percentage of PHDD at pretreatment [F(1, 1304) = 5.96, p = 0.015], after controlling for gender [F(1, 1304) = 0.29, p = 0.59] and BMI [F(1, 1304) = 0.90, p = 0.34]. Glucose was not significantly associated with the OCDS total score [F(1, 1304) = 0.12, p = 0.73], the OCDS Obsessive subscale [F(1, 1304) = 0.35, p = 0.56], or the OCDS Compulsive subscale [F(1, 1304) = 1.19, p = 0.28] scores, after controlling for gender and BMI. DISCUSSION: A link between pretreatment glucose levels and heavy drinking during treatment was found, suggesting a role of glucose in predicting heavy alcohol consumption. Although caution is needed in the interpretation of these results, elevated glucose and heavy drinking may be affected by a common mechanism and manipulations affecting glucose regulation may influence alcohol consumption.
Authors: Thomas Hillemacher; Thomas Kraus; Johannes Rauh; Julian Weiss; Anja Schanze; Helge Frieling; Julia Wilhelm; Annemarie Heberlein; Michael Gröschl; Wolfgang Sperling; Johannes Kornhuber; Stefan Bleich Journal: Alcohol Clin Exp Res Date: 2007-04-13 Impact factor: 3.455
Authors: Kenneth Blum; Thomas J H Chen; Brian Meshkin; B William Downs; Cory A Gordon; Seth Blum; Julie F Mangucci; Eric R Braverman; Vanessa Arcuri; Roger Deutsch; Manuel-Martinez- Pons Journal: Med Hypotheses Date: 2006-10-27 Impact factor: 1.538
Authors: Thomas Hillemacher; Christian Weinland; Annemarie Heberlein; Michael Gröschl; Anja Schanze; Helge Frieling; Julia Wilhelm; Johannes Kornhuber; Stefan Bleich Journal: Drug Alcohol Depend Date: 2008-09-24 Impact factor: 4.492
Authors: Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Noemi Malandrino; Antonio Mirijello; Cristina D'Angelo; Luisa Vonghia; Antonio Miceli; Esmeralda Capristo; George A Kenna; Giovanni Gasbarrini; Robert M Swift; Giovanni Addolorato Journal: Alcohol Clin Exp Res Date: 2008-09-25 Impact factor: 3.455
Authors: Luisa Vonghia; Lorenzo Leggio; Anna Ferrulli; Marco Bertini; Giovanni Gasbarrini; Giovanni Addolorato Journal: Eur J Intern Med Date: 2008-04-02 Impact factor: 4.487
Authors: Vasilios G Athyros; Evangelos N Liberopoulos; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Emmanuel S Ganotakis; Konstantinos Tziomalos; Anna I Kakafika; Asterios Karagiannis; Stylianos Lambropoulos; Moses Elisaf Journal: Angiology Date: 2007 Dec-2008 Jan Impact factor: 3.619
Authors: Lorenzo Leggio; Anna Ferrulli; Noemi Malandrino; Antonio Miceli; Esmeralda Capristo; Giovanni Gasbarrini; Giovanni Addolorato Journal: Alcohol Clin Exp Res Date: 2008-01-22 Impact factor: 3.455
Authors: Arpana Agrawal; Leah Wetherill; Kathleen K Bucholz; John Kramer; Samuel Kuperman; Michael T Lynskey; John I Nurnberger; Marc Schuckit; Jay A Tischfield; Howard J Edenberg; Tatiana Foroud; Laura J Bierut Journal: Addict Behav Date: 2012-03-19 Impact factor: 3.913
Authors: Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Antonio Nesci; Antonio Miceli; Noemi Malandrino; Esmeralda Capristo; Benedetta Canestrelli; Palmiero Monteleone; George A Kenna; Robert M Swift; Giovanni Addolorato Journal: Addict Biol Date: 2011-03-11 Impact factor: 4.280
Authors: Jie Wang; Hongying Du; Xiaoxian Ma; Brian Pittman; Laura Castracane; Ting-Kai Li; Kevin L Behar; Graeme F Mason Journal: J Neurochem Date: 2013-09-23 Impact factor: 5.372
Authors: Carolina L Haass-Koffler; Danielle E Giovenco; Mary R Lee; William H Zywiak; Suzanne M de la Monte; George A Kenna; Robert M Swift; Lorenzo Leggio Journal: Int J Neuropsychopharmacol Date: 2016-05-10 Impact factor: 5.176